Table 1.

The inhibitory effects of troglitazone on the proliferation of human cervical cancer SiHa cells

Troglitazone (μg/mL)	Time (h)
	24	48	72
100	3.34±0.27	9.37±1.54*	14.73±2.77*
200	12.42±1.10*	38.95±3.76*	60.15±6.87*
400	20.11±2.68*	52.33±8.15*	74.36±5.55*

Note: Data are presented as mean ± standard deviation.

^*P<0.05.